Safety of mogamulizumab in mycosis fungoides and Sézary syndrome: Final results from the phase 3 MAVORIC study Meeting Abstract


Authors: Kim, Y. H.; Bagot, M.; Zinzani, P. L.; Duvic, M.; Morris, S.; Kim, E.; Musiek, A.; Ortiz-Romero, P. L.; Elmets, C.; Eradat, H. A.; Magnolo, N.; Scarisbrick, J.; Dalle, S.; Fisher, D. C.; Shinohara, M.; Poligone, B.; Pro, B.; Quaglino, P.; Reddy, N.; Dreno, B.; Geskin, L. J.; Halwani, A. S.; Khot, A.; Beylot-Barry, M.; Korman, N.; Lansigan, F.; Horwitz, S. M.; Lamar, Z. S.; Moskowitz, A. J.; Wells, J.; Akilov, O. E.; Caballero, D.; Cowan, R.; Dummer, R.; Lechowicz, M. J.; Foss, F. M.; Iversen, L.; Miyagaki, T.; Wilcox, R.; Porcu, P.; Vermeer, M.; Abhyankar, S.; Kato, Y.; Pacheco, T.; Sano, S.; William, B. M.; Fenske, T. S.; Fukuhara, N.; Habe, K.; Hamada, T.; Kiyohara, E.; Kuss, B. J.; Lerner, A.; Mark, L.; Munoz, J.; Okamoto, H.; Querfeld, C.; Uehara, J.; Uhara, H.; Yonekura, K.; Huen, A.; Tobinai, K.; Tokura, Y.; Boh, E.; Nicolay, J.; Wada, H.; Leoni, M.; Ito, T.; Herr, F.; Sokol, L.
Abstract Title: Safety of mogamulizumab in mycosis fungoides and Sézary syndrome: Final results from the phase 3 MAVORIC study
Meeting Title: 61st Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 134
Issue: Suppl. 1
Meeting Dates: 2019 Dec 7-10
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2019-11-13
Language: English
ACCESSION: WOS:000577164606019
DOI: 10.1182/blood-2019-122778
PROVIDER: wos
Notes: Meeting Abstract: 5300 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Steven M Horwitz
    645 Horwitz
  2. Alison Moskowitz
    339 Moskowitz